Composition : Sitagliptin 50mg + Dapagliflozin 10mg
Form : Tablets
/
Pack : 10 X 10’s
/
Type : Alu Alu
Description : By preventing breakdown of GLP-1 and GIP,
Sitagliptin increases the secretion of insulin and suppresses the release of glucagon. As the blood glucose level approaches normal, the amounts of insulin released and glucagon suppressed diminishes, thus tending to prevent an "overshoot" and subsequent hypoglycemia.
Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), causes blood glucose to be eliminated through the urine, potently reduce intravascular volume through osmotic diuresis and natriuresis. Impressive results of the landmark SGLT2 inhibitor trials have becoming a powerful adjunctive therapy for the management of people with diabetes and HF-
ESC Heart Fail. 2019 Oct; 6(5): 927–935.
View more products with following salts
Dapagliflozin 10mg Sitagliptin 50mg